U.S. Markets closed

AxoGen (AXGN) in Focus: Stock Moves 5.7% Higher

Zacks Equity Research

AxoGen, Inc. (AXGN) was a big mover last session, as the company saw its shares rise by roughly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $2.80 to $3.08 in the past one-month time frame.

This generic drug company has seen no estimate revision over the past 30 days and its Zacks Consensus Estimate remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

AxoGen currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the industrial goods industry include Mallinckrodt plc (MNK), Teva Pharmaceutical Industries Ltd. (TEVA) and Impax Laboratories Inc. (IPXL). While Mallinckrodt and Teva Pharmaceutical Industries hold a Zacks Rank #1 (Strong Buy), Impax Laboratories carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

AXOGEN INC (AXGN): Free Stock Analysis Report

MALLINCKRODT PUBLIC LTD CO (MNK): Free Stock Analysis Report


IMPAX LABORATORIES INC (IPXL): Free Stock Analysis Report

Zacks Investment Research